A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies
scientific article published in December 2008
Author/s
author: Hagop Kantarjian, Vikas Gupta, Suzanne Kamel-Reid, Aaron Schimmer, Susan O'Brien, Farhad Ravandi, Gautam Borthakur, Francis Giles, Michael Andreeff, Mark Minden, Joseph M Brandwein, Bruce D. Cheson
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.